A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder
Amsterdam JD, Li Y, Soeller I, Rockwell K, Mao JJ, Shults J
Published in Journal of Clinical Psychopharmacology
Key Findings
Eight weeks of apigenin-standardized chamomile extract produced a significantly greater reduction in HAM-A anxiety scores than placebo.
Conclusions
Chamomile extract had modest anxiolytic activity in mild-to-moderate GAD.
Limitations
Small sample; short duration; effect attributable to the whole extract rather than isolated apigenin.
Supplements Studied
A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder.
Chamomile extract produced a significantly greater reduction in Hamilton Anxiety Rating Scale scores than placebo in patients with mild to moderate generalized anxiety disorder.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.